{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:28:20Z","timestamp":1695479300304},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1093\/ndt\/gfl302","type":"journal-article","created":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T15:36:57Z","timestamp":1151681817000},"page":"iii30-iii33","source":"Crossref","is-referenced-by-count":4,"title":["Management of cardiovascular risk in patients receiving calcineurin inhibitors\u2014a case report"],"prefix":"10.1093","volume":"21","author":[{"given":"Daniel","family":"Ser\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,7]]},"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/suppl_3\/iii30\/6835658\/gfl302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T22:54:20Z","timestamp":1507848860000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/suppl_3\/iii30\/1816178\/Management-of-cardiovascular-risk-in-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,1]]},"references-count":0,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2006,7]]},"published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfl302","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,7]]},"published":{"date-parts":[[2006,7,1]]}}}